Improving care and treatment options for women and girls with bleeding disorders

European Journal of Haematology

Volumn 95, Issue , 2015, Pages 2-10

  Kulkarni, Roshini ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bleeding disorders; Care; Coagulation factor deficiency; Females management; Treatment

Indexed keywords

BLOOD CLOTTING FACTOR;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; FEMALE; HUMAN; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; FEMALE; HUMANS; YOUNG ADULT;

EID: 84952803426     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12580     Document Type: Review

References (58)

1. Byams VR, Kouides PA, Kulkarni R, et al. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia 2011;17(Suppl. 1):6-13.
2. Peyvandi F, Garagiola I, Menegatti M. Gynecological and obstetrical manifestations of inherited bleeding disorders in women. J Thromb Haemost 2011;9(Suppl. 1):236-45.
3. Byams VR. Women with bleeding disorders. J Womens Health (Larchmt) 2007;16:1249-51.
4. Von Mackensen S. Quality of life in women with bleeding disorders. Haemophilia 2011;17(Suppl. 1):33-7.
5. Rhynders PA, Sayers CA, Presley RJ, Thierry JM. Providing young women with credible health information about bleeding disorders. Am J Prev Med 2014;47:674-80.
6. Koblinsky M, Chowdhury ME, Moran A, Ronsmans C. Maternal morbidity and disability and their consequences: neglected agenda in maternal health. J Health Popul Nutr 2012;30:124-30.
7. Ronsmans C, Chowdhury ME, Dasgupta SK, Ahmed A, Koblinsky M. Effect of parent's death on child survival in rural Bangladesh: a cohort study. Lancet 2010;375:2024-31.
8. On Demand Video: Women's Lives Matter: The Impact of Maternal Death on Families & Communities, 2014. Available at: http://fxb.harvard.edu/womens-lives-matter/ (accessed 15 January 2015).
9. Centers for Disease Control and Prevention. Blood Disorders in Women. Available at: http://www.cdc.gov/ncbddd/blooddisorders/women/research.html (accessed 15 August 2014)
10. Byams VR, Anderson BL, Grant AM, Atrash H, Schulkin J. Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologists. Am J Obstet Gynecol 2012;207:269.e1-5.
11. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med 2002;11:39-44.
12. HealthyPeople.gov. Available at: http://healthypeople.gov/2020 (accessed 15 August 2014).
13. Peyvandi F, Palla R, Menegatti M, Mannucci PM. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 2009;35:349-55.
14. Peyvandi F, Menegatti M, Palla R. Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management. Semin Thromb Hemost 2013;39:579-84.
15. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52.
16. Lee CA, Chi C, Pavord SR, Bolton-Maggs PH, Pollard D, Hinchcliffe-Wood A, Kadir RA, UK Haemophilia Centre Doctors' Organization. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006;12:301-36.
17. Diz-Küçükkaya R. Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome. Hematology Am Soc Hematol Educ Program 2013;2013:268-75.
18. Shetty S, Shelar T, Mirgal D, Nawadkar V, Pinto P, Shabhag S, Mukaddam A, Kulkarni B, Ghosh K. Rare coagulation factor deficiencies: a countrywide screening data from India. Haemophilia 2014;20:575-81.
19. Mauser-Bunschoten EP. Symptomatic Carriers of Hemophilia. World Federation of Hemophilia. Treatment of Hemophilia Series No. 46, 2008. Available at: http://www1.wfh.org/publications/files/pdf-1202.pdf (accessed 16 September 2014).
20. Olsson A, Hellgren M, Berntorp E, Ljung R, Baghaei F. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B. Blood Coagul Fibrinolysis 2014;25:471-5.
21. Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10:615-21.
22. Sharathkumar A, Hardesty B, Greist A, Salter J, Kerlin B, Heiman M, Sulkin M, Shapiro A. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C->T mutation. Haemophilia 2009;15:91-100.
23. Miesbach W, Alesci S, Geisen C, Oldenburg J. Association between phenotype and genotype in carriers of haemophilia A. Haemophilia 2011;17:246-51.
24. Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, van Amstel HK, van der Bom JG, van Diemen-Homan JE, Willemse J, Rosendaal FR. Bleeding in carriers of hemophilia. Blood 2006;108:52-6.
25. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988;59:349-52.
26. Di Michele DM, Gibb C, Lefkowitz JM, Ni Q, Gerber LM, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia 2014;20:e136-43.
27. James AH. Bleeding disorders in adolescents. Obstet Gynecol Clin North Am 2009;36:153-62.
28. American College of Obstetricians and Gynecologists (ACOG) Committee on Adolescent Health Care. ACOG Committee Opinion No. 349. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2006;108:1323-8.
29. Smith H. Menorrhagia. S Afr Pharm J 2013;80:16-8.
30. James AH, Ragni MV, Picozzi VJ. Bleeding disorders in premenopausal women: (another) public health crisis for hematology? Hematology Am Soc Hematol Educ Program 2006;2006:474-85.
31. James AH. Women and bleeding disorders. Haemophilia 2010;16(Suppl. 5):160-7.
32. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005;11:295-307.
33. Sharief LA, Kadir RA. Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia 2013;19:e349-57.
34. Shahbazi S, Moghaddam-Banaem L, Ekhtesari F, Ala FA. Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage. Blood Coagul Fibrinolysis 2012;23:603-7.
35. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
36. United Nations Population Fund (UNFPA). State of the World Population 2013. Motherhood in Childhood: Facing the Challenge of Adolescent Pregnancy. New York, NY: United Nations Population Fund; 2013.
37. James AH. Diagnosis and management of women with bleeding disorders - international guidelines and consensus from an international expert panel. Haemophilia 2011;17(Suppl. 1):3-5.
38. Demers C, Derzko C, David M, Douglas J, Society of Obstetricians and Gynecologists of Canada. Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can 2005;27:707-32.
39. Bowman M, Mundell G, Grabell J, Hopman WM, Rapson D, Lillicrap D, James P. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost 2008;6:2062-6.
40. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005;3:2619-26.
41. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006;4:766-73.
42. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009;7:1418-21.
43. O'Brien SH. Bleeding scores: are they really useful? Hematology Am Soc Hematol Educ Program 2012;2012:152-6.
44. James PD. No BS! Bleeding scores predict future bleeding. Blood 2014;123:4008-9.
45. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9.
46. Kadir RA, James AH. Reproductive Health in Women with Bleeding Disorders. World Federation of Hemophilia. Treatment of Hemophilia Series No. 48, 2009. Available at: http://www1.wfh.org/publication/files/pdf-1206.pdf (accessed 15 August 2014).
47. Kouides PA, Byams VR, Philipp CS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009;145:212-20.
48. ® Summary of Product Characteristics 2014. Available at: http://www.medicines.org.uk/EMC/medicine/21171/SPC/NovoSeven+1+mg+(50KIU)+.+NovoSeven+2+mg+(100+KIU)+.+NovoSeven+5+mg+(250+KIU)+.+NovoSeven+8+mg+(400+KIU)+powder+and+solvent+for+solution+for+injection/ (accessed 15 August 2014).
49. Novo Nordisk Press Release 2014. Available at: http://press.novonordisk-us.com/2014-07-07-FDA-Approves-NovoSeven-RT-for-the-Treatment-of-Glanzmanns-Thrombasthenia-GT-With-Refractoriness (accessed 15 January 2015). [Reference was added subsequent to the symposium, whilst drafting the manuscript].
50. ® Summary of Product Characteristics 2014. Available at: http://ec.europa.eu/health/documents/community-register/2012/20120903123586/anx_123586_en.pdf (accessed 15 August 2014).
51. ® Summary of Product Characteristics 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002719/WC500157553.pdf (accessed 15 August 2014).
52. European Medicines Agency. Guideline on Core SmPC for Human Plasma Derived and Recombinant Coagulant Factor IX Products. 24 May 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128994.pdf (accessed 15 August 2014).
53. Matteson KA, Rahn DD, Wheeler TL 2nd, Casiano E, Siddiqui NY, Harvie HS, Mamik MM, Balk EM, Sung VW, Society of Gynecologic Surgeons Systematic Review Group. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol 2013;121:632-43.
54. James AH, Kouides PA, Abdul-Kadir R, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol 2011;158:124-34.
55. Trigg DE, Stergiotou I, Peitsidis P, Kadir RA. A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 2012;18:25-33.
56. Bolton-Maggs PHB. The Rare Coagulation Disorders. World Federation of Hemophilia. Treatment of Hemophilia Series No. 36, 2006. Available at: http://www1.wfh.org/publication/files/pdf-1188.pdf (accessed 15 August 2014).
57. US Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. The Diagnosis, Evaluation and Management of von Willebrand Disease. NIH Publication No. 08-5832, December 2007. Available at: http://www.nhlbi.nih.gov/files/docs/guidelines/vwd.pdf (accessed 15 August 2014).
58. Centers for Disease Control and Prevention Screening Tool for Identifying Women with Menorrhagia for Testing and Evaluation for Underlying Bleeding Disorders. Available at: http://www.cdc.gov/ncbddd/blooddisorders/women/documents/menorrhagiafortesting.pdf (accessed 15 January 2015).